Matthew J. Schniederjan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Matthew J. Schniederjan has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Anna J. Janss
Department of Pediatric Neuro‐Oncology, Emory University School of Medicine, Atlanta, Georgia
1 shared publicationBahig Shehata
Department of Pathology, Emory University School of Medicine, Atlanta, Georgia
1 shared publicationDaniel J. Brat
Department of Pathology, Emory University School of Medicine, Atlanta, Georgia
1 shared publication- Natia Esiashvili
Emory University School of Medicine
1 shared publication
Latest Publications
- 26 August 2009
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 53 (7) , 1352-1354
De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system
We present a case of a 14‐year‐old male with a germline TP53 mutation who presented with synchronous primitive neuroectodermal tumor and choroid plexus carcinoma. Identification of synchronous brain tumors prompted genetic testing for predisposition to malignancy. Within 5 months of presentation, the child developed widely metastatic alveolar rhabdomyosarcoma. Patient DNA sequencing showed a TP53 allele with a premature stop codon in the oligomerization/nuclear export signal (NES) domain (R342ter). The child's parents, younger brother, paternal grandparents, and maternal grandmother, are without history of malignancy. The patient's brother tested negative for TP53 mutations. This case identifies a rare, de novo, germline TP53 mutation presenting with synchronous CNS malignancies and exhibiting a more fulminant course than typical cases of Li–Fraumeni syndrome. Pediatr Blood Cancer 2009; 53:1352–1354.
- 26 August 2009
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 53 (7) , 1352-1354
De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system
We present a case of a 14‐year‐old male with a germline TP53 mutation who presented with synchronous primitive neuroectodermal tumor and choroid plexus carcinoma. Identification of synchronous brain tumors prompted genetic testing for predisposition to malignancy. Within 5 months of presentation, the child developed widely metastatic alveolar rhabdomyosarcoma. Patient DNA sequencing showed a TP53 allele with a premature stop codon in the oligomerization/nuclear export signal (NES) domain (R342ter). The child's parents, younger brother, paternal grandparents, and maternal grandmother, are without history of malignancy. The patient's brother tested negative for TP53 mutations. This case identifies a rare, de novo, germline TP53 mutation presenting with synchronous CNS malignancies and exhibiting a more fulminant course than typical cases of Li–Fraumeni syndrome. Pediatr Blood Cancer 2009; 53:1352–1354.